The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Broad Antiretroviral Activity and Resistance Profile of the Novel Human Immunodeficiency Virus Integrase Inhibitor Elvitegravir (JTK-303/GS-9137)
Open accessAbstract
Integrase (IN), an essential enzyme of human immunodeficiency virus (HIV), is an attractive antiretroviral drug target. The antiviral activity and resistance profile in vitro of a novel IN inhibitor, elvitegravir (EVG) (also known as JTK-303/GS-9137), currently being developed for the treatment of HIV-1 infection are described. EVG blocked the integration of HIV-1 cDNA through the inhibition of DNA strand transfer. EVG inhibited the replication of HIV-1, including various subtypes and multiple-drug-resistant clinical isolates, and HIV-2 strains with a 50% effective concentration in the subnanomolar to nanomolar range. EVG-resistant variants were selected in two independent inductions, and a total of 8 amino acid substitutions in the catalytic core domain of IN were observed. Among the observed IN mutations, T66I and E92Q substitutions mainly contributed to EVG resistance. These two primary resistance mutations are located in the active site, and other secondary mutations identified are proximal to these primary mutations. The EVG-selected IN mutations, some of which represent novel IN inhibitor resistance mutations, conferred reduced susceptibility to other IN inhibitors, suggesting that a common mechanism is involved in resistance and potential cross-resistance. The replication capacity of EVG-resistant variants was significantly reduced relative to both wild-type virus and other IN inhibitor-resistant variants selected by L-870,810. EVG and L-870,810 both inhibited the replication of murine leukemia virus and simian immunodeficiency virus, suggesting that IN inhibitors bind to a conformationally conserved region of various retroviral IN enzymes and are an ideal drug for a range of retroviral infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,405
Inhibitors of Strand Transfer That Prevent Integration and Inhibit HIV-1 Replication in Cells
Hazuda, D. J., Felock, P., Witmer, M., Wolfe, A., Stillmock, K., Grobler, J. A., Espeseth, A., Gabryelski, L., Schleif, W., Blau, C., et al. (2000) · Science · doi:10.1126/science.287.5453.646 · Cited by 1,131
In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors
Condra, J. H., Schleif, W. A., Blahy, O. M., Gabryelski, L. J., Graham, D. J., Quintero, J., Rhodes, A., Robbins, H. L., Roth, E., Shivaprakash, M., et al. (1995) · Nature · doi:10.1038/374569a0 · Cited by 974
Dyda, F., Hickman, A. B., Jenkins, T. M., Engelman, A., Craigie, R., & Davies, D. R. (1994) · Science · doi:10.1126/science.7801124 · Cited by 810 · cited 1×
“IN consists of three domains: an N-terminal zinc finger domain and a C-terminal DNA-binding domain flank a central catalytic core domain (CCD) that plays a critical role in its enzymatic activity (13, 14).”
BackgroundClavel, F., & Hance, A. J. (2004) · New England Journal of Medicine · doi:10.1056/nejm2ra025195 · Cited by 800
HIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells
Cherepanov, P., Maertens, G., Proost, P., Devreese, B., Van Beeumen, J., Engelborghs, Y., De Clercq, E., & Debyser, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209278200 · Cited by 704 · cited 1×
“IN has also been proposed to function with several cellular factors including IN interactor 1 (Ini1) (27) and lens-epithelium-derived growth factor (LEDGF/p75) (7).”
BackgroundIntegrase inhibitors to treat HIV/Aids
Pommier, Y., Johnson, A. A., & Marchand, C. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1660 · Cited by 688
A quantitative assay for HIV DNA integration in vivo
Butler, S. L., Hansen, M. S. T., & Bushman, F. D. (2001) · Nature Medicine · doi:10.1038/87979 · Cited by 687
HIV-1 DNA integration: Mechanism of viral DNA cleavage and DNA strand transfer
Engelman, A., Mizuuchi, K., & Craigie, R. (1991) · Cell · doi:10.1016/0092-8674(91)90297-c · Cited by 655
Grinsztejn, B., Nguyen, B.-Y., Katlama, C., Gatell, J. M., Lazzarin, A., Vittecoq, D., Gonzalez, C. J., Chen, J., Harvey, C. M., & Isaacs, R. D. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60597-2 · Cited by 574
Kuiken, C., Foley, B., Freed, E., Hahn, B., Marx, P., McCutchan, F., Mellors, J., Wolinsky, S., & Korber, B. (2002) · doi:10.2172/1184349 · Cited by 570
Binding and Stimulation of HIV-1 Integrase by a Human Homolog of Yeast Transcription Factor SNF5
Kalpana, G. V., Marmon, S., Wang, W., Crabtree, G. R., & Goff, S. P. (1994) · Science · doi:10.1126/science.7801128 · Cited by 530
Goldgur, Y., Craigie, R., Cohen, G. H., Fujiwara, T., Yoshinaga, T., Fujishita, T., Sugimoto, H., Endo, T., Murai, H., & Davies, D. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13040 · Cited by 496
Site-directed mutagenesis of double-stranded DNA by the polymerase chain reaction
Weiner, M. P., Costa, G. L., Schoettlin, W., Cline, J., Mathur, E., & Bauer, J. C. (1994) · Gene · doi:10.1016/0378-1119(94)90641-6 · Cited by 481
Correct integration of retroviral DNA in vitro
Brown, P. O., Bowerman, B., Varmus, H. E., & Bishop, J. M. (1987) · Cell · doi:10.1016/0092-8674(87)90287-x · Cited by 460
Bukrinsky, M. I., Sharova, N., McDonald, T. L., Pushkarskaya, T., Tarpley, W. G., & Stevenson, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6125 · Cited by 451
Three new structures of the core domain of HIV-1 integrase: An active site that binds magnesium
Goldgur, Y., Dyda, F., Hickman, A. B., Jenkins, T. M., Craigie, R., & Davies, D. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9150 · Cited by 380
Wang, J.-Y. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.7333 · Cited by 335
Hazuda, D. J., Anthony, N. J., Gomez, R. P., Jolly, S. M., Wai, J. S., Zhuang, L., Fisher, T. E., Embrey, M., Guare, J. P., Egbertson, M. S., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402357101 · Cited by 333
Novel HIV-1 Integrase Inhibitors Derived from Quinolone Antibiotics
Sato, M., Motomura, T., Aramaki, H., Matsuda, T., Yamashita, M., Ito, Y., Kawakami, H., Matsuzaki, Y., Watanabe, W., Yamataka, K., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0600139 · Cited by 328
Self-citationChackerian, B., Long, E. M., Luciw, P. A., & Overbaugh, J. (1997) · Journal of Virology · doi:10.1128/jvi.71.5.3932-3939.1997 · Cited by 267
LaFemina, R. L., Schneider, C. L., Robbins, H. L., Callahan, P. L., LeGrow, K., Roth, E., Schleif, W. A., & Emini, E. A. (1992) · Journal of Virology · doi:10.1128/jvi.66.12.7414-7419.1992 · Cited by 259
Shibata, R., Kawamura, M., Sakai, H., Hayami, M., Ishimoto, A., & Adachi, A. (1991) · Journal of Virology · doi:10.1128/jvi.65.7.3514-3520.1991 · Cited by 245
Tisdale, M., Myers, R. E., Maschera, B., Parry, N. R., Oliver, N. M., & Blair, E. D. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.8.1704 · Cited by 180
White, K. L., Margot, N. A., Wrin, T., Petropoulos, C. J., Miller, M. D., & Naeger, L. K. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3437-3446.2002 · Cited by 180
Molecular mechanisms in retrovirus DNA integration
Asante‐Appiah, E., & Skalka, A. M. (1997) · Antiviral Research · doi:10.1016/s0166-3542(97)00046-6 · Cited by 172
MOBILITY OF AN HIV-1 INTEGRASE ACTIVE SITE LOOP IS CORRELATED WITH CATALYTIC ACTIVITY
Greenwald, J., Le, V. P., Butler, S. L., Bushman, F. D., & Choe, S. (1999) · Biochemistry · doi:10.1021/bi9907173 · Cited by 167
Gatanaga, H., Suzuki, Y., Tsang, H., Yoshimura, K., Kavlick, M. F., Nagashima, K., Gorelick, R. J., Mardy, S., Tang, C., Summers, M. F., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108005200 · Cited by 156
Kodama, E. N., Kohgo, S., Kitano, K., Machida, H., Gatanaga, H., Shigeta, S., Matsuoka, M., Ohrui, H., & Mitsuya, H. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1539-1546.2001 · Cited by 135
Self-citationInteraction between Human Immunodeficiency Virus Type 1 Reverse Transcriptase and Integrase Proteins
Hehl, E. A., Joshi, P., Kalpana, G. V., & Prasad, V. R. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5056-5067.2004 · Cited by 132
Genetic analysis of the human immunodeficiency virus type 1 integrase protein
Shin, C., Taddeo, B., Haseltine, W. A., & Farnet, C. M. (1994) · Journal of Virology · doi:10.1128/jvi.68.3.1633-1642.1994 · Cited by 129
Fikkert, V., Maele, B. V., Vercammen, J., Hantson, A., Remoortel, B. V., Michiels, M., Gurnari, C., Pannecouque, C. C., Maeyer, M. D., Engelborghs, Y., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.21.11459-11470.2003 · Cited by 104
Sharma, P., & Crumpacker, C. S. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8846-8851.1997 · Cited by 103
In VitroAssays for Activities of Retroviral Integrase
Chow, S. A. (1997) · Methods · doi:10.1006/meth.1997.0484 · Cited by 96
Savarino, A. (2007) · Retrovirology · doi:10.1186/1742-4690-4-21 · Cited by 86
Myint, L., Matsuda, M., Matsuda, Z., Yokomaku, Y., Chiba, T., Okano, A., Yamada, K., & Sugiura, W. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.2.444-452.2004 · Cited by 85
Nameki, D., Kodama, E. N., Ikeuchi, M., Mabuchi, N., Otaka, A., Tamamura, H., Ohno, M., Fujii, N., & Matsuoka, M. (2004) · Journal of Virology · doi:10.1128/jvi.79.2.764-770.2005 · Cited by 85
Self-citationFikkert, V., Hombrouck, A., Remoortel, B. V., Maeyer, M. D., Pannecouque, C. C., Clercq, E. D., Debyser, Z., & Witvrouw, M. (2004) · AIDS · doi:10.1097/00002030-200410210-00006 · Cited by 84
Neuveut, C., & Jeang, K. T. (1996) · Journal of Virology · doi:10.1128/jvi.70.8.5572-5581.1996 · Cited by 69
Sugiura, W., Matsuda, Z., Yokomaku, Y., Hertogs, K., Larder, B. A., Oishi, T., Okano, A., Shiino, T., Tatsumi, M., Matsuda, M., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.708-715.2002 · Cited by 67
Lee, M. C., Deng, J. N., Briggs, J. M., & Duan, Y. (2005) · Biophysical Journal · doi:10.1529/biophysj.104.058446 · Cited by 58
Gleenberg, I. O., Avidan, O., Goldgur, Y., Herschhorn, A., & Hizi, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414679200 · Cited by 55
Kaufmann, G. R., & Cooper, D. A. (2000) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00131-4 · Cited by 48
Chakrabarti, L. A., Metzner, K. J., Ivanovic, T., Cheng, H., Virelizier, J., Connor, R. I., & Cheng‐Mayer, C. (2002) · Journal of Virology · doi:10.1128/jvi.77.2.1245-1256.2003 · Cited by 45
Molecular dynamics studies of the full-length integrase–DNA complex
Luca, L. D., Vistoli, G., Pedretti, A., Barreca, M. L., & Chimirri, A. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.211 · Cited by 42
Reinke, R., Lee, D. J., & Robinson, W. E. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.10.3301-3303.2002 · Cited by 19
Kehlenbeck, S., Betz, U. A. K., Birkmann, A., Fast, B., Goller, A., Henninger, K., Lowinger, T. B., Marrero, D., Paessens, A., Paulsen, D., et al. (2006) · Journal of Virology · doi:10.1128/jvi.00306-06 · Cited by 14
Cited by
Electrifying Organic Synthesis
Wiebe, A., Gieshoff, T., Möhle, S., Rodrigo, E., Zirbes, M., & Waldvogel, S. R. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201711060 · Cited by 1,530
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
HIV-1 Antiretroviral Drug Therapy
Arts, E. J., & Hazuda, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007161 · Cited by 851
Hirsch, M. S., Günthard, H. F., Schapiro, J. M., Brun‐Vézinet, F., Clotet, B., Hammer, S. M., Johnson, V. A., Kuritzkes, D. R., Mellors, J. W., Pillay, D., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/589297 · Cited by 573
Sax, P. E., DeJesus, E., Mills, A., Zolopa, A., Cohen, C., Wohl, D., Gallant, J. E., Liu, H. C., Zhong, L., Yale, K., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60917-9 · Cited by 444
Metadata
- Authors
- Shimura, K., Kodama, E., Sakagami, Y., Matsuzaki, Y., Watanabe, W., Yamataka, K., Watanabe, Y., Ohata, Y., Doi, S., Sato, M., Kano, M., Ikeda, S., & Matsuoka, M.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2008-01-15
- Volume
- 82
- Issue
- 2
- Pages
- 764-774
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2154190260
- Cited by
- 343
- References
- 47
- FWCI
- 16.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.